25 XP   0   0   10

Novacyt
Buy, Hold or Sell?

Let's analyse Novacyt together

PenkeI guess you are interested in Novacyt. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Novacyt. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Novacyt

I send you an email if I find something interesting about Novacyt.

Quick analysis of Novacyt (30 sec.)










What can you expect buying and holding a share of Novacyt? (30 sec.)

How much money do you get?

How much money do you get?
p0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
p163.13
Expected worth in 1 year
p163.13
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
p0.00
Return On Investment
0.0%

For what price can you sell your share?

Current Price per Share
p71.40
Expected price per share
p47.00 - p82.40
How sure are you?
50%

1. Valuation of Novacyt (5 min.)




Live pricePrice per Share (EOD)

p71.40

2. Growth of Novacyt (5 min.)




Is Novacyt growing?

Current yearPrevious yearGrowGrow %
How rich?$143.5m$143.5m0.000.0%

How much money is Novacyt making?

Current yearPrevious yearGrowGrow %
Making money0.00-$27.6m$27.6m?
Net Profit Margin0.0%-105.5%--

How much money comes from the company's main activities?

3. Financial Health of Novacyt (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#121 / 334

Most Revenue
#142 / 334

Most Profit
#301 / 334

Most Efficient
#245 / 334

What can you expect buying and holding a share of Novacyt? (5 min.)

Welcome investor! Novacyt's management wants to use your money to grow the business. In return you get a share of Novacyt.

What can you expect buying and holding a share of Novacyt?

First you should know what it really means to hold a share of Novacyt. And how you can make/lose money.

Speculation

The Price per Share of Novacyt is p71.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Novacyt.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Novacyt, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p163.13. Based on the TTM, the Book Value Change Per Share is p0.00 per quarter. Based on the YOY, the Book Value Change Per Share is p-37.66 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Novacyt.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps0.000.0%0.000.0%-0.45-0.6%-0.12-0.2%-0.07-0.1%
Usd Book Value Change Per Share0.000.0%0.000.0%-0.47-0.7%0.410.6%0.200.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%-0.47-0.7%0.410.6%0.200.3%
Usd Price Per Share0.77-0.77-1.41-3.53-1.88-
Price to Earnings Ratio0.00-0.00--3.10-53.92--98.90-
Price-to-Total Gains Ratio-3.00-69.32-105.04-
Price to Book Ratio0.38-0.38-0.69-96.01-79.72-
Price-to-Total Gains Ratio-3.00-69.32-105.04-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.8897154
Number of shares1123
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.41
Usd Total Gains Per Share0.000.41
Gains per Quarter (1123 shares)0.00455.85
Gains per Year (1123 shares)0.001,823.41
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
100-10018231813
200-10036473636
300-10054705459
400-10072947282
500-10091179105
600-1001094010928
700-1001276412751
800-1001458714574
900-1001641116397
1000-1001823418220

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.00.01.00.0%0.02.01.00.0%1.03.01.020.0%1.08.01.010.0%1.011.01.07.7%
Book Value Change Per Share0.00.01.00.0%1.01.01.033.3%2.02.01.040.0%5.04.01.050.0%7.05.01.053.8%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.013.00.0%
Total Gains per Share0.00.01.00.0%1.01.01.033.3%2.02.01.040.0%5.04.01.050.0%7.05.01.053.8%

Fundamentals of Novacyt

About Novacyt

Novacyt S.A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments. The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases. The Lab21 Products segment develops, manufactures, and distributes a range of protein-based infectious disease in-vitro diagnostic device (IVD) products. The IT-IS International segment develops and manufactures PCR devices for the life sciences and food testing industry. The company was incorporated in 2006 and is based in Vélizy-Villacoublay, France.

Fundamental data was last updated by Penke on 2024-04-23 11:56:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.

1.1. Profitability of Novacyt.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Novacyt earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • A Net Profit Margin of 0.0% means that 0.00 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Novacyt:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-105.5%+105.5%
TTM-5Y-19.5%+19.5%
5Y-19.5%10Y-43.9%+24.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--12.4%+12.4%
TTM--20.4%+20.4%
YOY-105.5%-14.8%-90.7%
5Y-19.5%-21.3%+1.8%
10Y-43.9%-25.0%-18.9%
1.1.2. Return on Assets

Shows how efficient Novacyt is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • 0.0% Return on Assets means that Novacyt generated 0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Novacyt:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-15.8%+15.8%
TTM-5Y4.6%-4.6%
5Y4.6%10Y-11.4%+15.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--4.1%+4.1%
TTM--4.7%+4.7%
YOY-15.8%-4.8%-11.0%
5Y4.6%-4.0%+8.6%
10Y-11.4%-5.2%-6.2%
1.1.3. Return on Equity

Shows how efficient Novacyt is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • 0.0% Return on Equity means Novacyt generated 0.00 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Novacyt:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-19.3%+19.3%
TTM-5Y7.0%-7.0%
5Y7.0%10Y-18.0%+25.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--4.2%+4.2%
TTM--5.8%+5.8%
YOY-19.3%-5.7%-13.6%
5Y7.0%-6.3%+13.3%
10Y-18.0%-7.1%-10.9%

1.2. Operating Efficiency of Novacyt.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Novacyt is operating .

  • Measures how much profit Novacyt makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Novacyt:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-78.9%+78.9%
TTM-5Y-6.0%+6.0%
5Y-6.0%10Y-29.8%+23.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--24.3%+24.3%
TTM--16.4%+16.4%
YOY-78.9%-13.7%-65.2%
5Y-6.0%-19.9%+13.9%
10Y-29.8%-24.5%-5.3%
1.2.2. Operating Ratio

Measures how efficient Novacyt is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are 0.00 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Novacyt:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.789-1.789
TTM-5Y0.855-0.855
5Y0.85510Y1.054-0.199
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.442-1.442
TTM-1.439-1.439
YOY1.7891.431+0.358
5Y0.8551.436-0.581
10Y1.0541.374-0.320

1.3. Liquidity of Novacyt.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Novacyt is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.00 means the company has 0.00 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Novacyt:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY5.250-5.250
TTM-5Y2.621-2.621
5Y2.62110Y1.894+0.727
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.726-2.726
TTM-2.732-2.732
YOY5.2503.510+1.740
5Y2.6213.617-0.996
10Y1.8943.499-1.605
1.3.2. Quick Ratio

Measures if Novacyt is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • A Quick Ratio of 0.00 means the company can pay off 0.00 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Novacyt:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY5.022-5.022
TTM-5Y2.331-2.331
5Y2.33110Y1.484+0.847
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.491-1.491
TTM-1.633-1.633
YOY5.0222.113+2.909
5Y2.3312.295+0.036
10Y1.4842.255-0.771

1.4. Solvency of Novacyt.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Novacyt assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Novacyt to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.18 means that Novacyt assets are financed with 18.2% credit (debt) and the remaining percentage (100% - 18.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Novacyt:

  • The MRQ is 0.182. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.182. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.182TTM0.1820.000
TTM0.182YOY0.1820.000
TTM0.1825Y0.296-0.114
5Y0.29610Y0.316-0.020
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1820.389-0.207
TTM0.1820.386-0.204
YOY0.1820.335-0.153
5Y0.2960.442-0.146
10Y0.3160.461-0.145
1.4.2. Debt to Equity Ratio

Measures if Novacyt is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Novacyt to the Medical Devices industry mean.
  • A Debt to Equity ratio of 22.3% means that company has 0.22 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Novacyt:

  • The MRQ is 0.223. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.223. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.223TTM0.2230.000
TTM0.223YOY0.2230.000
TTM0.2235Y0.485-0.262
5Y0.48510Y0.504-0.019
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2230.551-0.328
TTM0.2230.554-0.331
YOY0.2230.479-0.256
5Y0.4850.622-0.137
10Y0.5040.674-0.170

2. Market Valuation of Novacyt

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Novacyt generates.

  • Above 15 is considered overpriced but always compare Novacyt to the Medical Devices industry mean.
  • A PE ratio of 0.00 means the investor is paying 0.00 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Novacyt:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-3.102+3.102
TTM-5Y53.915-53.915
5Y53.91510Y-98.900+152.815
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--1.704+1.704
TTM--2.081+2.081
YOY-3.102-2.978-0.124
5Y53.915-2.379+56.294
10Y-98.900-1.726-97.174
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Novacyt:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-5.642+5.642
TTM-5Y-29.698+29.698
5Y-29.69810Y-224.299+194.601
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--1.578+1.578
TTM--2.973+2.973
YOY-5.642-6.318+0.676
5Y-29.698-5.307-24.391
10Y-224.299-5.171-219.128
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Novacyt is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.38 means the investor is paying 0.38 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Novacyt:

  • The EOD is 0.438. Based on the equity, the company is cheap. +2
  • The MRQ is 0.377. Based on the equity, the company is cheap. +2
  • The TTM is 0.377. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.438MRQ0.377+0.061
MRQ0.377TTM0.3770.000
TTM0.377YOY0.693-0.316
TTM0.3775Y96.007-95.630
5Y96.00710Y79.717+16.290
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.4381.876-1.438
MRQ0.3772.372-1.995
TTM0.3772.434-2.057
YOY0.6933.217-2.524
5Y96.0073.893+92.114
10Y79.7174.245+75.472
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Novacyt compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0%-37.6620%32.576-100%16.310-100%
Book Value Per Share--163.135163.1350%163.1350%105.875+54%55.941+192%
Current Ratio----0%5.250-100%2.621-100%1.894-100%
Debt To Asset Ratio--0.1820.1820%0.1820%0.296-38%0.316-42%
Debt To Equity Ratio--0.2230.2230%0.2230%0.485-54%0.504-56%
Dividend Per Share----0%-0%-0%-0%
Eps----0%-36.4310%-9.6820%-5.4370%
Gross Profit Margin----0%1.217-100%1.120-100%1.169-100%
Market Cap5042710680.000+14%4343514252.0004343514252.0000%7980766024.000-46%20028889279.920-78%10664205679.960-59%
Net Profit Margin----0%-1.0550%-0.1950%-0.4390%
Operating Margin----0%-0.7890%-0.0600%-0.2980%
Operating Ratio----0%1.789-100%0.855-100%1.054-100%
Pb Ratio0.438+14%0.3770.3770%0.693-46%96.007-100%79.717-100%
Pe Ratio----0%-3.1020%53.915-100%-98.9000%
Price Per Share71.400+14%61.50061.5000%113.000-46%283.590-78%150.995-59%
Price To Free Cash Flow Ratio----0%-5.6420%-29.6980%-224.2990%
Quick Ratio----0%5.022-100%2.331-100%1.484-100%
Return On Assets----0%-0.1580%0.046-100%-0.1140%
Return On Equity----0%-0.1930%0.070-100%-0.1800%
Total Gains Per Share----0%-37.6620%32.576-100%16.310-100%
Usd Book Value--143570657.600143570657.6000%143570657.6000%93178069.884+54%49232341.260+192%
Usd Book Value Change Per Share----0%-0.4690%0.406-100%0.203-100%
Usd Book Value Per Share--2.0332.0330%2.0330%1.319+54%0.697+192%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps----0%-0.4540%-0.1210%-0.0680%
Usd Free Cash Flow----0%-17626084.5000%-386312.8190%-399942.8040%
Usd Market Cap62837217.783+14%54124531.09454124531.0940%99448325.425-46%249579989.317-78%132886666.978-59%
Usd Price Per Share0.890+14%0.7660.7660%1.408-46%3.534-78%1.882-59%
Usd Profit----0%-27664666.1000%-7635628.7940%-4311959.1430%
Usd Revenue--144100.786144100.7860%26217944.000-99%29861400.016-100%15552022.324-99%
Usd Total Gains Per Share----0%-0.4690%0.406-100%0.203-100%
 EOD+3 -2MRQTTM+0 -0YOY+3 -75Y+9 -1310Y+8 -11

3.2. Fundamental Score

Let's check the fundamental score of Novacyt based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Book Ratio (EOD)Between0-10.438
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than10.182
Debt to Equity Ratio (MRQ)Less than10.223
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total3/9 (33.3%)

3.3. Technical Score

Let's check the technical score of Novacyt based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5080.250
Ma 20Greater thanMa 5053.843
Ma 50Greater thanMa 10049.042
Ma 100Greater thanMa 20053.082
OpenGreater thanClose70.000
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Other Current Assets  2,2621,4693,731199,967203,69837,478241,176-285,302-44,126



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
 As reported
Total Liabilities -
Total Stockholder Equity+ -
Total Assets = -

Assets

Total Current Assets
Cash And Cash Equivalents 44,126
Other Current Assets -44,126
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities
Total Current Liabilities  (as reported)0
Total Current Liabilities  (calculated)0
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)0
+/-0
Other
Cash and Short Term Investments 44,126
Net Debt -44,126



Balance Sheet

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
1,509
4,032
3,180
26,588
17,106
30,442
30,205
29,310
26,540
234,276
183,697
140,901
0
0140,901183,697234,27626,54029,31030,20530,44217,10626,5883,1804,0321,509
   > Total Current Assets 
505
2,600
1,904
6,070
5,609
7,360
9,684
9,023
5,897
204,985
158,783
127,238
0
0127,238158,783204,9855,8979,0239,6847,3605,6096,0701,9042,600505
       Cash And Cash Equivalents 
0
0
840
2,326
527
2,856
3,857
1,020
1,542
91,765
101,746
86,973
44,126
44,12686,973101,74691,7651,5421,0203,8572,8565272,32684000
       Short-term Investments 
42
1,673
1,000
10
1,164
10
9
9
9
9
9
9
0
0999999101,164101,0001,67342
       Net Receivables 
0
0
632
2,048
2,030
2,567
4,075
3,994
1,854
79,592
43,597
34,721
0
034,72143,59779,5921,8543,9944,0752,5672,0302,04863200
       Inventory 
114
263
248
1,337
1,488
1,614
1,724
2,116
2,084
29,888
11,461
3,027
0
03,02711,46129,8882,0842,1161,7241,6141,4881,337248263114
   > Long-term Assets 
1,004
1,432
1,275
20,518
11,497
23,082
20,521
20,286
20,643
29,291
24,914
13,663
0
013,66324,91429,29120,64320,28620,52123,08211,49720,5181,2751,4321,004
       Property Plant Equipment 
501
444
155
532
683
1,096
1,396
1,073
2,971
3,902
6,382
3,272
0
03,2726,3823,9022,9711,0731,3961,096683532155444501
       Goodwill 
0
0
0
19,042
9,256
16,466
14,618
14,545
13,599
17,877
11,471
6,646
0
06,64611,47117,87713,59914,54514,61816,4669,25619,042000
       Long Term Investments 
0
0
0
0
0
0
4
4
0
0
0
0
0
0000044000000
       Intangible Assets 
0
0
1,051
1,097
1,111
5,333
4,297
4,457
3,685
4,255
3,710
3,121
0
03,1213,7104,2553,6854,4574,2975,3331,1111,0971,05100
       Long-term Assets Other 
43
1,679
1,011
19
1,274
180
208
209
183
105
73
730
0
0730731051832092081801,274191,0111,67943
> Total Liabilities 
2,401
2,393
862
6,061
6,582
12,674
8,087
11,156
14,072
83,566
41,882
25,685
0
025,68541,88283,56614,07211,1568,08712,6746,5826,0618622,3932,401
   > Total Current Liabilities 
550
1,146
619
4,692
4,335
8,817
6,910
8,920
5,849
74,142
38,904
24,236
0
024,23638,90474,1425,8498,9206,9108,8174,3354,6926191,146550
       Short-term Debt 
42
1,673
1,000
10
1,164
10
2,467
2,808
1,379
414
424
609
0
06094244141,3792,8082,467101,164101,0001,67342
       Short Long Term Debt 
0
0
209
282
1,270
3,499
2,779
3,115
2,190
0
0
0
0
00002,1903,1152,7793,4991,27028220900
       Accounts payable 
0
0
231
2,133
1,816
2,087
1,550
2,496
3,922
5,228
1,363
278
0
02781,3635,2283,9222,4961,5502,0871,8162,13323100
       Other Current Liabilities 
0
0
299
2,353
864
2,806
2,893
3,616
505
7,599
12,558
22,810
0
022,81012,5587,5995053,6162,8932,8068642,35329900
   > Long-term Liabilities 
1,850
1,247
244
1,369
2,247
3,857
1,177
2,236
8,223
9,424
2,978
1,449
0
01,4492,9789,4248,2232,2361,1773,8572,2471,3692441,2471,850
       Other Liabilities 
0
0
17
555
144
1,101
212
222
247
7,460
1,532
1,186
0
01,1861,5327,4602472222121,1011445551700
       Deferred Long Term Liability 
0
0
0
0
186
187
139
315
261
124
69
0
0
00691242613151391871860000
> Total Stockholder Equity
0
0
2,250
20,273
10,524
17,768
22,117
18,154
12,468
150,710
141,815
115,216
0
0115,216141,815150,71012,46818,15422,11717,76810,52420,2732,25000
   Common Stock
0
0
197
418
479
1,161
2,229
2,264
3,309
4,053
4,053
4,053
0
04,0534,0534,0533,3092,2642,2291,16147941819700
   Retained Earnings Total Equity0000000000000
   Accumulated Other Comprehensive Income 0-860-19-881-1,893-1,307-2,681-2,432-2,084-2,120-977-544-453
   Capital Surplus 
0
0
0
0
0
0
0
56,705
56,455
60,866
0
0
0
00060,86656,45556,7050000000
   Treasury Stock000-59-169-1730000000
   Other Stockholders Equity 
0
0
1
-30
-82
-2,481
52,139
51,496
46,931
49,741
50,574
49,718
0
049,71850,57449,74146,93151,49652,139-2,481-82-30100



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue11,564
Cost of Revenue--
Gross Profit11,56411,564
 
Operating Income (+$)
Gross Profit11,564
Operating Expense--
Operating Income11,56411,564
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense-0
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-0
Net Interest Income-
 
Pretax Income (+$)
Operating Income11,564
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-11,564
EBIT - interestExpense = 0
0
0
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-0
Earnings Before Interest and Taxes (EBITDA)11,564
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income-
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Novacyt
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Novacyt. The general trend of Novacyt is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Novacyt's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Novacyt.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 70.00 < 77.87 < 82.40.

The bearish price targets are: 68.00 > 55.13 > 47.00.

Tweet this
Novacyt Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Novacyt. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Novacyt Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Novacyt. The current macd is 6.02748171.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Novacyt price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Novacyt. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Novacyt price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Novacyt Daily Moving Average Convergence/Divergence (MACD) ChartNovacyt Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Novacyt. The current adx is 45.47.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Novacyt shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Novacyt Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Novacyt. The current sar is 59.23.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Novacyt Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Novacyt. The current rsi is 80.25. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Novacyt Daily Relative Strength Index (RSI) ChartNovacyt Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Novacyt. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Novacyt price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Novacyt Daily Stochastic Oscillator ChartNovacyt Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Novacyt. The current cci is 138.04.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Novacyt Daily Commodity Channel Index (CCI) ChartNovacyt Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Novacyt. The current cmo is 65.16.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Novacyt Daily Chande Momentum Oscillator (CMO) ChartNovacyt Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Novacyt. The current willr is -8.70795761.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Novacyt Daily Williams %R ChartNovacyt Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Novacyt.

Novacyt Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Novacyt. The current atr is 4.9000837.

Novacyt Daily Average True Range (ATR) ChartNovacyt Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Novacyt. The current obv is 6,259,028.

Novacyt Daily On-Balance Volume (OBV) ChartNovacyt Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Novacyt. The current mfi is 79.20.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Novacyt Daily Money Flow Index (MFI) ChartNovacyt Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Novacyt.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Novacyt Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Novacyt based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5080.250
Ma 20Greater thanMa 5053.843
Ma 50Greater thanMa 10049.042
Ma 100Greater thanMa 20053.082
OpenGreater thanClose70.000
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Novacyt with someone you think should read this too:
  • Are you bullish or bearish on Novacyt? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Novacyt? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Novacyt

I send you an email if I find something interesting about Novacyt.


Comments

How you think about this?

Leave a comment

Stay informed about Novacyt.

Receive notifications about Novacyt in your mailbox!